The second coming of consumer genomics with 3 predictions for 2018
Several fundamentals have changed to accelerate growth in the genomics space, spurring our second look into the sector.
Exclusive: Counsyl’s oncology unit falters; 24 lose jobs
Counsyl is shutting down its oncology business just seven months after launching the division. Some 24 jobs will be lost as the company concentrates its efforts in women's health and carrier screening.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Genetics company Counsyl targets oncologists in bid to boost patient screening
The goal of this new initiative is to make it easier for oncologists to have their patients tested for genetic mutations linked to cancer.
Peter Thiel-backed carrier screening upstart Counsyl lays off 27 employees
Counsyl's layoffs are in sales support, marketing, design and engineering.
Planning to get pregnant? Counsyl bringing carrier screening to the mainstream
Bay Area startup Counsyl aims to bring carrier screening to the mainstream, so that parents can know if their child is likely to have a serious genetic disease.
Peter Thiel has turned to biotech, specifically focused on anti-aging
Co-founder of PayPal and initial investor in Facebook, Peter Thiel knows where to put his money and has an eye for what will be successful – that much is clear. But now, his eye has drifted over to the biotech world, and once again, the money is rolling in. According to MIT Technology Review, Thiel […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.